Nov 3, 2022 8:30 am EDT Volition Announces the Launch of the Nu.Q® Vet Cancer Screening Test in the U.S. and Europe Through Heska's Reference Laboratories
Aug 10, 2022 4:10 pm EDT VolitionRx Limited Announces Second Quarter 2022 Financial Results and Business Update
Aug 8, 2022 4:10 pm EDT VolitionRx Limited Schedules Second Quarter 2022 Earnings Conference Call and Business Update
Aug 2, 2022 4:10 pm EDT VolitionRx Limited Announces Closing of $6.9 Million Underwritten Public Offering of Common Stock
Jul 29, 2022 8:30 am EDT VolitionRx Limited Announces Pricing of $6 Million Underwritten Public Offering of Common Stock
